• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

POTEE 通过调控 SPHK1/p65 信号通路促进结直肠癌发生发展。

POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.

机构信息

Department of General Surgery, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Ave., 510515, Guangzhou, Guangdong Province, China.

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Ave., 510515, Guangzhou, Guangdong Province, China.

出版信息

Cell Death Dis. 2019 Nov 13;10(11):863. doi: 10.1038/s41419-019-2046-7.

DOI:10.1038/s41419-019-2046-7
PMID:31723122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6853991/
Abstract

Aberrant gene expression plays critical roles in the development of colorectal cancer (CRC). Here we show that POTEE, which was identified as a member E of POTE ankyrin domain family, was significantly upregulated in colorectal tumors and predicted poor overall survival of CRC patients. In CRC cells, POTEE could act as an oncogene and could promote cell growth, cell-cycle progression, inhibit apoptosis, and elevates xenograft tumor growth. Mechanically, we used microarray analysis and identified a POTEE/SPHK1/p65 signaling axis, which affected the biological functions of CRC cells. Further evaluation showed that overexpression of POTEE could increase the protein expression of SPHK1, followed by promoting the phosphorylation and activation of p65 protein. Altogether, our findings suggested a POTEE/SPHK1/p65 signaling axis could promote colorectal tumorigenesis and POTEE might potentially serve as a novel biomarker for the diagnosis and an intervention of colorectal cancer.

摘要

异常基因表达在结直肠癌(CRC)的发生发展中起着关键作用。在这里,我们发现 POTEE 作为 POTE 锚蛋白结构域家族的 E 成员,在结直肠肿瘤中显著上调,并预测 CRC 患者的总生存率较差。在 CRC 细胞中,POTEE 可以作为癌基因,促进细胞生长、细胞周期进程、抑制细胞凋亡,并提高异种移植肿瘤的生长。在机制上,我们利用微阵列分析鉴定了一个 POTEE/SPHK1/p65 信号轴,该信号轴影响 CRC 细胞的生物学功能。进一步的评估表明,POTEE 的过表达可以增加 SPHK1 的蛋白表达,进而促进 p65 蛋白的磷酸化和激活。总的来说,我们的研究结果表明,POTEE/SPHK1/p65 信号轴可以促进结直肠肿瘤的发生,POTEE 可能作为结直肠癌诊断和干预的新的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/3b3e2becd1ad/41419_2019_2046_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/6aaef9d7194a/41419_2019_2046_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/15ce453e4aba/41419_2019_2046_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/9c70b49c8883/41419_2019_2046_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/598e3bb1d289/41419_2019_2046_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/af785ff62bac/41419_2019_2046_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/3b3e2becd1ad/41419_2019_2046_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/6aaef9d7194a/41419_2019_2046_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/15ce453e4aba/41419_2019_2046_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/9c70b49c8883/41419_2019_2046_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/598e3bb1d289/41419_2019_2046_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/af785ff62bac/41419_2019_2046_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9243/6853991/3b3e2becd1ad/41419_2019_2046_Fig6_HTML.jpg

相似文献

1
POTEE drives colorectal cancer development via regulating SPHK1/p65 signaling.POTEE 通过调控 SPHK1/p65 信号通路促进结直肠癌发生发展。
Cell Death Dis. 2019 Nov 13;10(11):863. doi: 10.1038/s41419-019-2046-7.
2
POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.POTEE 通过激活 Rac1/Cdc42 通路促进结直肠癌进展。
Exp Cell Res. 2020 May 1;390(1):111933. doi: 10.1016/j.yexcr.2020.111933. Epub 2020 Mar 3.
3
SphK1 promotes tumor cell migration and invasion in colorectal cancer.鞘氨醇激酶1促进结直肠癌中肿瘤细胞的迁移和侵袭。
Tumour Biol. 2016 May;37(5):6831-6. doi: 10.1007/s13277-015-4542-4. Epub 2015 Dec 10.
4
SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination.鞘氨醇激酶 1 通过调节 TRAF6 诱导的 ULK1 泛素化介导的自噬促进结直肠癌的进展和转移。
Cancer Gene Ther. 2024 Mar;31(3):410-419. doi: 10.1038/s41417-023-00711-1. Epub 2023 Dec 22.
5
SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.鞘氨醇激酶1(SphK1)通过调节结肠癌细胞中磷酸化粘着斑激酶(p-FAK)的表达来调控细胞迁移和上皮-间质转化(EMT)相关标志物的表达。
Int J Mol Med. 2017 May;39(5):1277-1284. doi: 10.3892/ijmm.2017.2921. Epub 2017 Mar 17.
6
Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.鞘氨醇激酶1表达增加预示着结直肠癌患者发生远处转移及预后不良。
Anticancer Res. 2019 Feb;39(2):663-670. doi: 10.21873/anticanres.13161.
7
Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.长链非编码 RNA MEG3 的下调促进结直肠腺癌细胞增殖,并通过上调 TGF-β1 及其下游鞘氨醇激酶 1 抑制细胞凋亡。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8265-8272. doi: 10.26355/eurrev_201812_16522.
8
CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis.细胞周期蛋白依赖性激酶5通过调节细胞外信号调节激酶5-激活蛋白1轴在人类结直肠癌中发挥肿瘤促进作用。
Cell Death Dis. 2016 Oct 13;7(10):e2415. doi: 10.1038/cddis.2016.333.
9
Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.长链非编码 RNA HNF1A-AS1 提示结直肠癌预后不良,并通过激活 Wnt/β-连环蛋白信号通路促进肿瘤发生。
Biomed Pharmacother. 2017 Dec;96:877-883. doi: 10.1016/j.biopha.2017.10.033. Epub 2017 Nov 6.
10
SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer.SphK1 驱动的自噬增强了结直肠癌细胞中黏着斑相关的 paxillin 介导的转移。
Cancer Med. 2021 Sep;10(17):6010-6021. doi: 10.1002/cam4.4129. Epub 2021 Jul 16.

引用本文的文献

1
Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning.通过迁移学习对全癌基因组中背景突变率进行元素特异性估计。
NPJ Precis Oncol. 2025 Mar 29;9(1):92. doi: 10.1038/s41698-025-00871-3.
2
Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer.鉴定TTLL8、POTEE和PKMYT1为卵巢癌中具有免疫原性的癌症相关抗原及潜在免疫治疗靶点。
Oncoimmunology. 2025 Dec;14(1):2460276. doi: 10.1080/2162402X.2025.2460276. Epub 2025 Jan 31.
3
NFκB signalling in colorectal cancer: Examining the central dogma of IKKα and IKKβ signalling.

本文引用的文献

1
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis.CD36 通过泛素化 GPC4 抑制 β-catenin/c-myc 介导的糖酵解,从而抑制结直肠肿瘤发生。
Nat Commun. 2019 Sep 4;10(1):3981. doi: 10.1038/s41467-019-11662-3.
2
The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.p300/YY1/miR-500a-5p/HDAC2 信号轴调控人结直肠癌细胞增殖。
Nat Commun. 2019 Feb 8;10(1):663. doi: 10.1038/s41467-018-08225-3.
3
Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift.
结直肠癌中的核因子κB信号传导:审视IKKα和IKKβ信号传导的中心法则
Heliyon. 2024 Jun 12;10(12):e32904. doi: 10.1016/j.heliyon.2024.e32904. eCollection 2024 Jun 30.
4
GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis.GRK2介导的SAV1降解引发类风湿关节炎中滑膜成纤维样细胞的增生。
Acta Pharm Sin B. 2024 Mar;14(3):1222-1240. doi: 10.1016/j.apsb.2023.12.007. Epub 2023 Dec 16.
5
Deciphering the omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways.解析奥密克戎变异株:整合组学分析揭示关键生物标志物和病理生理途径。
J Transl Med. 2024 Feb 29;22(1):219. doi: 10.1186/s12967-024-05022-z.
6
POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1.POTEE 通过激活 SUMO 化 Rac1 诱导侵袭伪足形成从而促进乳腺癌细胞的恶性转化。
Mol Oncol. 2024 Mar;18(3):620-640. doi: 10.1002/1878-0261.13568. Epub 2023 Dec 27.
7
Is a Highly Expressed Therapy Target in Myxoid Liposarcoma.是黏液样脂肪肉瘤中高表达的治疗靶点。
Cancers (Basel). 2023 Nov 7;15(22):5308. doi: 10.3390/cancers15225308.
8
POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma.POTEE 突变可作为肺腺癌免疫检查点抑制剂的潜在预测性生物标志物。
Invest New Drugs. 2023 Aug;41(4):556-563. doi: 10.1007/s10637-023-01375-2. Epub 2023 Jun 15.
9
Histaminergic System and Inflammation-Related Genes in Normal Large Intestine and Tissues: Transcriptional Profiles and Relations.组织:正常大肠组织中与组胺能系统和炎症相关的基因:转录谱及其关系。
Int J Mol Sci. 2023 Mar 3;24(5):4913. doi: 10.3390/ijms24054913.
10
Whole genome sequencing of Malaysian colorectal cancer patients reveals specific druggable somatic mutations.马来西亚结直肠癌患者的全基因组测序揭示了特定的可靶向治疗的体细胞突变。
Front Mol Biosci. 2023 Feb 14;9:997747. doi: 10.3389/fmolb.2022.997747. eCollection 2022.
尽管存在代谢压力和表观遗传漂移,但鞘脂信号失衡作为癌性表型的核心支持者仍持续存在。
Oncotarget. 2019 Jan 11;10(4):449-479. doi: 10.18632/oncotarget.26533.
4
The outer membrane protein Tp92 of Treponema pallidum induces human mononuclear cell death and IL-8 secretion.梅毒密螺旋体外膜蛋白 Tp92 诱导人单核细胞死亡和白细胞介素-8 分泌。
J Cell Mol Med. 2018 Dec;22(12):6039-6054. doi: 10.1111/jcmm.13879. Epub 2018 Sep 14.
5
Expression of the POTE gene family in human ovarian cancer.人卵巢癌中 POTE 基因家族的表达。
Sci Rep. 2018 Nov 20;8(1):17136. doi: 10.1038/s41598-018-35567-1.
6
Identification of MΦ specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMs.鉴定巨噬细胞特异性 POTEE 的表达:其通过 TAMs 中的蛋白-蛋白相互作用在 mTORC2 激活中的作用。
Cell Immunol. 2019 Jan;335:30-40. doi: 10.1016/j.cellimm.2018.10.010. Epub 2018 Nov 3.
7
The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.鞘氨醇激酶-1/鞘氨醇-1-磷酸轴在癌症中的作用:抗肿瘤治疗的潜在靶点。
Pharmacol Ther. 2019 Mar;195:85-99. doi: 10.1016/j.pharmthera.2018.10.011. Epub 2018 Oct 19.
8
GSDMB promotes non-canonical pyroptosis by enhancing caspase-4 activity.GSDMB 通过增强半胱天冬酶-4 的活性促进非经典的细胞焦亡。
J Mol Cell Biol. 2019 Jun 1;11(6):496-508. doi: 10.1093/jmcb/mjy056.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.白藜芦醇通过抑制 SphK1 介导的 NF-κB 激活抑制野百合碱诱导的肺动脉重构。
Life Sci. 2018 Oct 1;210:140-149. doi: 10.1016/j.lfs.2018.08.071. Epub 2018 Sep 1.